United States· US:55292-201_399a2f13-1fa5-5557-e063-6294a90a48a2
Chemet
A medicinal product containing succimer, registered in United States by Recordati Rare Diseases, Inc..
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- SUCCIMER
- Manufacturer
- Recordati Rare Diseases, Inc.
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc115529220111100 CAPSULE in 1 BOTTLE (55292-201-11)
- ndc1155292-201-11
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Succimer in 10 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomChemet 100mg capsulesImported (United States)
- FranceSUCCICAPTAL 100 mg, géluleSERB
- IrelandRENOCIS 1 mg kit for radiopharmaceutical preparationCIS bio International
- SwitzerlandSuccicaptal, KapselnCuratis AG
- CzechiaSUCCICAPTAL
- GermanyDmsa RotopRotop Pharmaka Gmbh
- NetherlandsTechnescan DMSA, 1,2 mg kit voor radiofarmaceutisch preparaatCurium Netherlands B.V.
- NorwaySuccicaptalLaboratoires SERB
Authorised across Europe · EMA
The same active substance is authorised in 7 EEA countries. Names it is sold under:
- Czechia · Technescan Dmsa
- Germany · Dmsa Rotop, Technescan Dmsa
- Spain · Dmsa Technescan Curium Pharma Spain
- France · Succicaptal, Technescan Dmsa
- Italy · Renocis
- Malta · Succicaptal
- Sweden · Renocis
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/bcc4cf9a-a2d0-4afd-ba77-8a81e95b60d0 GET /v1/drugs/bcc4cf9a-a2d0-4afd-ba77-8a81e95b60d0?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "100",
"substance": "SUCCIMER",
"productndc": "55292-201",
"dosage_form": "CAPSULE",
"dea_schedule": null,
"strength_unit": "mg/1",
"application_number": "NDA019998",
"marketing_category": "NDA"
}See everything about succimer.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.